Xu JF - Search Results

1

The Surgical and Therapeutic Activities of Non-Functional Pancreatic Neuroendocrine Tumors at a High-Volume Institution.

Zhang WH, Xu JF, Hu YH, Qin Y, Chen J, Yu XJ, Xu XW, Ji SR. Zhang WH, et al. Among authors: xu xw, xu jf. Cancers (Basel). 2023 Mar 24;15(7):1955. doi: 10.3390/cancers15071955. Cancers (Basel). 2023. PMID: 37046616 Free PMC article.

2

Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway.

Xu J, Li Z, Zhuo Q, Ye Z, Fan G, Gao H, Ji S, Yu X, Xu X, Liu W, Xu W. Xu J, et al. Front Oncol. 2022 Jan 26;12:822039. doi: 10.3389/fonc.2022.822039. eCollection 2022. Front Oncol. 2022. PMID: 35155257 Free PMC article.

3

MEN1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression.

Xu J, Ye Z, Zhuo Q, Gao H, Qin Y, Lou X, Zhang W, Wang F, Wang Y, Jing D, Fan G, Zhang Y, Chen X, Chen J, Xu X, Yu X, Ji S. Xu J, et al. Cancer Res. 2023 Jul 5;83(13):2226-2247. doi: 10.1158/0008-5472.CAN-22-3599. Cancer Res. 2023. PMID: 36939378

4

Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment.

Xu J, Zhang W, Lou X, Ye Z, Qin Y, Chen J, Xu X, Yu X, Ji S. Xu J, et al. Cancer Biol Med. 2023 Sep 28;20(10):721-7. doi: 10.20892/j.issn.2095-3941.2023.0284. Cancer Biol Med. 2023. PMID: 37771139 Free PMC article. No abstract available.

5

The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.

Ye Z, Li Q, Hu Y, Hu H, Xu J, Guo M, Zhang W, Lou X, Wang Y, Gao H, Jing D, Fan G, Qin Y, Zhang Y, Chen X, Chen J, Xu X, Yu X, Liu M, Ji S. Ye Z, et al. Cancer Lett. 2024 Apr 28;588:216769. doi: 10.1016/j.canlet.2024.216769. Epub 2024 Mar 2. Cancer Lett. 2024. PMID: 38438098

6

Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1.

Wang T, Hu Q, Li B, Fan G, Jing D, Xu J, Hu Y, Dang Q, Ji S, Zhou C, Zhuo Q, Xu X, Qin Y, Yu X, Li Z. Wang T, et al. Cell Prolif. 2024 Nov;57(11):e13694. doi: 10.1111/cpr.13694. Epub 2024 Jun 27. Cell Prolif. 2024. PMID: 38938061 Free PMC article.

7

MEN1 Deficiency-Driven Activation of the β-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance.

Xu J, Lou X, Wang F, Zhang W, Xu X, Ye Z, Zhuo Q, Wang Y, Jing D, Fan G, Chen X, Zhang Y, Zhou C, Chen J, Qin Y, Yu X, Ji S. Xu J, et al. Adv Sci (Weinh). 2024 Sep;11(35):e2308417. doi: 10.1002/advs.202308417. Epub 2024 Jul 23. Adv Sci (Weinh). 2024. PMID: 39041891 Free PMC article.

8

Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor.

Wang Y, Ye Z, Lou X, Xu J, Jing D, Zhou C, Qin Y, Chen J, Xu X, Yu X, Ji S. Wang Y, et al. Hum Cell. 2024 Sep;37(5):1522-1534. doi: 10.1007/s13577-024-01107-5. Epub 2024 Jul 30. Hum Cell. 2024. PMID: 39078546

9

Unraveling the mysteries of MGMT: Implications for neuroendocrine tumors.

Jiang J, Xu J, Ji S, Yu X, Chen J. Jiang J, et al. Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189184. doi: 10.1016/j.bbcan.2024.189184. Epub 2024 Sep 18. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39303858 Review.

10

Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2^Prame complex.

Zhang W, Li L, Cai L, Liang Y, Xu J, Liu Y, Zhou L, Ding C, Zhang Y, Zhao H, Qin J, Shao Z, Wei W, Jia L. Zhang W, et al. Cell Death Differ. 2021 Jun;28(6):1926-1940. doi: 10.1038/s41418-020-00724-5. Epub 2021 Jan 27. Cell Death Differ. 2021. PMID: 33504946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

672 results

Search Page

Filters